BioAro

BioAro is a biotech firm with focus in Genome/Exome Sequencing, Pharmacogenomics, Metabolomic and Microbiome analyses with a strong focus on Cardiovascular Health. We help personalize treatment plans, predict and prevent cardiac events, and monitor disease progression. The company's lab capabilities include NGS and LCMS, supporting advanced Research in Canada.